Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
Security class unavailable · CUSIP: 171757107
Event date: 2021-02-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,727,072
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000222
- Form type
- SC 13G
- Filer
- Cidara Therapeutics, Inc.
- CIK
- CIK 1610618
- Filed
- Mar 05, 2021
- Reporting period
- Feb 25, 2021
- Description
- Schedule 13G beneficial ownership